Research

The roots of addiction risk may lie in how young brains function long before substance use begins, according to a new study from Weill Cornell Medicine.

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why many cancer patients experience debilitating pain as a side effect, according to a new study by Weill Cornell Medicine and Wake Forest University School of Medicine researchers.

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body’s immunity.

Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators.

Combining heart failure education with real-time communication tools can better equip home health aides to care for adults with heart failure in the home, according to a new randomized clinical trial.

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system’s ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine.

A Weill Cornell Medicine investigator and other members of a technical advisory group to the World Health Organization and United Nations Children’s Fund have outlined measures that nations can take to ensure that children’s health is accounted for within climate change goals. 

As Medicaid funding cuts enacted through the One Big Beautiful Bill Act are expected to reduce health coverage among adults, researchers and clinicians warn that children are at increasing risk of unintended downstream effects.

Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat cells and may result in type 2 diabetes in people with obesity.

A team led by Weill Cornell Medicine and University of Miami’s Miller School of Medicine investigators has been awarded a five-year, $4 million grant from the National Institute on Drug Abuse (NIDA) for health economics research.

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. 

A three-year, $4.5 million grant from BD²: Breakthrough Discoveries for thriving with Bipolar Disorder to Weill Cornell Medicine investigators, in collaboration with Stanford Medicine, will support a three-pronged research project to map the brain circuits that contribute to mood shifts in bipolar disorder and help develop personalized therapies for the condition.

Dr. Mocco will lead a large team of neurosurgeons and other experts who specialize in diseases that affect the blood vessels in the brain, known as cerebrovascular disease; brain and spinal tumors; movement disorders; and other diseases of the brain, spine and nerves that branch out from the brain and spinal cord. 

Albert Einstein College of Medicine has received a five-year, $10.8 million grant from the National Institutes of Health (NIH) to create the New York Regional Diabetes Research Center (NYR-DRC), a newly expanded multi-institutional center co-led with the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine. 

Researchers at Weill Cornell Medicine have received a five-year grant from the National Institute of Diabetes and Digestive and Kidney Diseases to support TRACE, a Tool for Reproducible, Accurate Contour Estimation.

Dr. Lauren Henderson, a physician-scientist whose research focuses on children with difficult-to-treat juvenile idiopathic arthritis and other autoimmune disorders, has been awarded the 10th annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today. 

Researchers have discovered that free radicals generated at a specific site in non-neuronal brain cells called astrocytes, may promote dementia, according to a Weill Cornell Medicine study.

Dr. Judy Tung, a leading expert in internal medicine and primary care, has been named chief of the Division of General Internal Medicine in the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Aug. 1.

Among preterm newborns, greater exposure to the mother’s voice after birth appeared to speed up the maturation of a key language-related brain circuit, in a small clinical trial conducted by investigators at Weill Cornell Medicine, Burke Neurological Institute and Stanford Medicine.

Dr. Ekta Khurana highlights the goals of a recently paused Department of Defense grant investigating treatment-resistant prostate cancer—and the consequences of further inaction.